Dr. Abhishek Maiti, MD
Claim this profileM D Anderson Cancer Center
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
7 reported clinical trials
10 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
FLT3 positive
IDH positive
TP53 positive
2Acute Myeloid Leukemia
FLT3 positive
IDH positive
TP53 positive
Affiliated Hospitals
Clinical Trials Abhishek Maiti, MD is currently running
Azacitidine + Venetoclax + NK Cells
for Acute Myeloid Leukemia
This trial is testing if adding special immune cells from a healthy person to two existing cancer drugs can better control a type of blood cancer. The immune cells help fight cancer and infections. The two drugs work by killing cancer cells. These drugs have been used together to treat this type of blood cancer, showing improved response rates and survival compared to using one of the drugs alone.
Recruiting1 award Phase 1
HC-7366 + Azacitidine + Venetoclax
for AML
To find a recommended dose of HC-7366 to patients with AML. The safety and effects of this drug combination will also be studied.
Recruiting1 award Phase 1
More about Abhishek Maiti, MD
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Abhishek Maiti, MD has experience with
- Venetoclax
- Azacitidine
- Decitabine
- HC-7366
- Q702
- Cedazuridine
Breakdown of trials Abhishek Maiti, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Mixed phenotype acute leukemia
Biphenotypic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Abhishek Maiti, MD specialize in?
Abhishek Maiti, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 positive patients, or patients who are IDH positive.
Is Abhishek Maiti, MD currently recruiting for clinical trials?
Yes, Abhishek Maiti, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Abhishek Maiti, MD has studied deeply?
Yes, Abhishek Maiti, MD has studied treatments such as Venetoclax, Azacitidine, Decitabine.
What is the best way to schedule an appointment with Abhishek Maiti, MD?
Apply for one of the trials that Abhishek Maiti, MD is conducting.
What is the office address of Abhishek Maiti, MD?
The office of Abhishek Maiti, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.